Al Jalila Foundation, a member of the Mohammed Bin Rashid Al Maktoum Global Initiatives, announced that it will establish the UAE’s first robotic biobank in partnership with the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) and the Dubai Health Authority (DHA). The collaboration is set to advance medical research in genetic disorders, cancer, and other chronic diseases and pandemics.
Set to open in 2023 with a capacity to manage seven million specimens, the biobank will be one of the world’s largest in terms of sample capacity. The facility will be located at the Mohammed Bin Rashid Medical Research Institute, part of Al Jalila Foundation, in Dubai Healthcare City.
The UAE’s first robotic biobank will attract strategic collaboration opportunities with key healthcare authorities and partners across the region and globally. It will operate in the best practices in biobanking and adhere to the highest compliance regulations and ethical standards for the collection, processing, storage, and analysis of biological samples and data for research into genetic and environmental factors that impact human health and disease.
Click to read more.